Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

December 12, 2000

Primary Completion Date

July 15, 2002

Study Completion Date

February 10, 2009

Conditions
Lymphoma
Interventions
DRUG

cisplatin

DRUG

dexamethasone

DRUG

gemcitabine hydrochloride

Trial Locations (13)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

E1C 6ZB

Moncton Hospital, Moncton

A1B 3V6

Newfoundland Cancer Treatment and Research Foundation, St. John's

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

K7L 5P9

Kingston Regional Cancer Centre, Kingston

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

L5M 2N1

Credit Valley Hospital, Mississauga

P7A 7T1

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

NCIC Clinical Trials Group

NETWORK